+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genentech, Inc.  - logo

Genentech, Inc., a biotechnology company, engages in the research, development, manufacture, and marketing of biotechnology products for treating patients with serious or life-threatening diseases in the United States. It offers molecular entities and medicines in the areas of oncology, immunology, neuroscience, metabolism, and infectious diseases. The company was founded in 1976 and is headquartered in South San Francisco, California. Genentech operates as a subsidiary of Roche Holdings, Inc.

From
Melanoma Drugs Market Report 2025 - Product Thumbnail Image

Melanoma Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Follicular Lymphoma Treatment Market Report 2025 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Non Hodgkin Lymphoma (NHL) Market Report 2025 - Product Thumbnail Image

Non Hodgkin Lymphoma (NHL) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Biosimilar Interleukins Market Report 2025 - Product Thumbnail Image

Biosimilar Interleukins Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Biosimilar Lymphocyte Modulator Market Report 2025 - Product Thumbnail Image

Biosimilar Lymphocyte Modulator Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Multiple Myeloma- Pipeline Insight, 2025 - Product Thumbnail Image

Multiple Myeloma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 230 Pages
  • Global
From
Basal Cell Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

Extensive-Stage Small Cell Lung Cancer (ESCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • December 2025
  • 282 Pages
  • Global
From
From
From
Loading Indicator